228 related articles for article (PubMed ID: 25067837)
1. A true theranostic approach to medicine: towards tandem sensor detection and removal of endotoxin in blood.
Thompson M; Blaszykowski C; Sheikh S; Romaschin A
Biosens Bioelectron; 2015 May; 67():3-10. PubMed ID: 25067837
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
Martin EL; Ranieri VM
Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?
Harm S; Falkenhagen D; Hartmann J
Int J Artif Organs; 2014 Mar; 37(3):222-32. PubMed ID: 24744167
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation.
Tsuzuki H; Tani T; Ueyama H; Kodama M
J Surg Res; 2001 Sep; 100(1):127-34. PubMed ID: 11516215
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B-conjugated alpha 2-macroglobulin as an adjunctive therapy to sepsis: Modes of action and impact on lethality.
Birkenmeier G; Nicklisch S; Pockelt C; Mossie A; Steger V; Gläser C; Hauschildt S; Usbeck E; Huse K; Sack U; Bauer M; Schäfer A
J Pharmacol Exp Ther; 2006 Aug; 318(2):762-71. PubMed ID: 16705081
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin removal: history of a mission.
Ronco C
Blood Purif; 2014; 37 Suppl 1():5-8. PubMed ID: 24457488
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release.
Zhou M; Wu R; Dong W; Jacob A; Wang P
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R84-92. PubMed ID: 17989144
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
9. A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients.
Amoureux MC; Hegyi E; Le D; Grandics P; Tong H; Szathmary S
J Endotoxin Res; 2004; 10(2):85-95. PubMed ID: 15119999
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.
Esteban E; Ferrer R; Alsina L; Artigas A
Mediators Inflamm; 2013; 2013():507539. PubMed ID: 24249974
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and application of a novel ligand for affinity chromatography based removal of endotoxin from antibodies.
McAllister LA; Hixon MS; Schwartz R; Kubitz DS; Janda KD
Bioconjug Chem; 2007; 18(2):559-66. PubMed ID: 17315943
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of polymyxin B endotoxin removal from extracorporeal blood flow: molecular interactions.
Vesentini S; Soncini M; Fiore GB; Redaelli A
Contrib Nephrol; 2010; 167():45-54. PubMed ID: 20519898
[TBL] [Abstract][Full Text] [Related]
13. Blood purification therapy for sepsis.
Sakata H; Yonekawa M; Kawamura A
Transfus Apher Sci; 2006 Dec; 35(3):245-51. PubMed ID: 17110167
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anti-endotoxin effects of polymyxin B in a feline model of endotoxemia.
Sharp CR; DeClue AE; Haak CE; Honaker AR; Reinero CR
J Feline Med Surg; 2010 Apr; 12(4):278-85. PubMed ID: 20156699
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.
Gao JP; Huang M; Li N; Wang PF; Chen HL; Xu QP
J Zhejiang Univ Sci B; 2011 Apr; 12(4):264-72. PubMed ID: 21462381
[TBL] [Abstract][Full Text] [Related]
16. Low-dose polymyxin: an option for therapy of Gram-negative sepsis.
Harm S; Gabor F; Hartmann J
Innate Immun; 2016 May; 22(4):274-83. PubMed ID: 26993088
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study on the safety and efficacy of a new polymyxin B-immoblized resin column in treatment of LPS-induced sepsis beagles.
Li Y; Yang Z; Hu J; Lin Z
Animal Model Exp Med; 2022 Apr; 5(2):161-171. PubMed ID: 35234365
[TBL] [Abstract][Full Text] [Related]
19. Mapping residue-specific contacts of polymyxin B with lipopolysaccharide by saturation transfer difference NMR: insights into outer-membrane disruption and endotoxin neutralization.
Bhunia A; Bhattacharjya S
Biopolymers; 2011; 96(3):273-87. PubMed ID: 20683937
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin apheresis for sepsis.
Shimizu T; Endo Y; Tsuchihashi H; Akabori H; Yamamoto H; Tani T
Transfus Apher Sci; 2006 Dec; 35(3):271-82. PubMed ID: 17118710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
